December 06, 2022

Assessing the Impact of the Recent Supreme Court Session on the Drug and Medical Device Industry and Upcoming Preemption Battles

ACI’s 2022 Drug & Medical Device Litigation Conference

Overview

Ruben Gonzalez is presenting “Assessing the Impact of the Recent Supreme Court Session on the Drug and Medical Device Industry and Upcoming Preemption Battles” at the 2022 Drug & Medical Device Litigation Conference in New York City. The panel discussion will include:

  • Looking Beyond Albrecht: Analyzing the potential implications of Dobbs v. Jackson Women’s Health Organization on future preemption battles involving state attempts to ban FDA-approved drugs
  • Could the Court’s recent decision limiting the authority of the EPA potentially impact the FDA’s future ability to enforce their regulations in the drug and device space?
  • Views from Supreme Court practitioners on how the current division in the Court is impacting their approach to argument and their decisions on appellate issues
Location

New York Marriot Marquis
1535 Broadway
New York, New York 10036

More Information
The Faegre Drinker Biddle & Reath LLP website uses cookies to make your browsing experience as useful as possible. In order to have the full site experience, keep cookies enabled on your web browser. By browsing our site with cookies enabled, you are agreeing to their use. Review Faegre Drinker Biddle & Reath LLP's cookies information for more details.